• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).

作者信息

Fisher B, Glass A, Redmond C, Fisher E R, Barton B, Such E, Carbone P, Economou S, Foster R, Frelick R, Lerner H, Levitt M, Margolese R, MacFarlane J, Plotkin D, Shibata H, Volk H

出版信息

Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.

DOI:10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9
PMID:194679
Abstract
摘要

相似文献

1
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.
2
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较：西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
3
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.联合化疗（CMFVP）与左旋苯丙氨酸氮芥（L-PAM）治疗腋窝淋巴结阳性的可手术乳腺癌：西南肿瘤学组研究
Cancer. 1982 Aug 1;50(3):423-34. doi: 10.1002/1097-0142(19820801)50:3<423::aid-cncr2820500307>3.0.co;2-o.
4
Controlled study with 1-phenylalanine mustard (l-PAM) and 5-fluorouracil (5-FU) plus or minus prednisone in advanced breast cancer.关于1-苯丙氨酸氮芥（左旋苯丙氨酸氮芥，l-PAM）和5-氟尿嘧啶（5-FU）联合或不联合泼尼松用于晚期乳腺癌的对照研究。
Tumori. 1976 Mar-Apr;62(2):193-6. doi: 10.1177/030089167606200208.
5
Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.原发性乳腺癌的辅助联合化疗：CMF方案
Recent Results Cancer Res. 1977(62):134-42. doi: 10.1007/978-3-642-81174-6_20.
6
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard.
Cancer. 1976 Nov;38(5):1882-6. doi: 10.1002/1097-0142(197611)38:5<1882::aid-cncr2820380503>3.0.co;2-h.
7
Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.乳腺癌辅助化疗期间的急性毒性：美国国家外科辅助乳腺和肠道项目（NSABP）对1717例接受单药和联合用药患者的经验。
Cancer Treat Rep. 1981 May-Jun;65(5-6):363-76.
8
Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.国家乳腺与肠道外科辅助治疗项目（NSABP）临床试验的十年结果，该试验评估了左旋苯丙氨酸氮芥（L-PAM）在原发性乳腺癌治疗中的应用。
J Clin Oncol. 1986 Jun;4(6):929-41. doi: 10.1200/JCO.1986.4.6.929.
9
1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers.
Cancer. 1979 Sep;44(3):847-57. doi: 10.1002/1097-0142(197909)44:3<847::aid-cncr2820440309>3.0.co;2-3.
10
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.
Am J Clin Oncol. 1982 Aug;5(4):371-81. doi: 10.1097/00000421-198208000-00005.

引用本文的文献

1
A Short History of Bernard Fisher's Contributions to Randomized Clinical Trials.伯纳德·费舍尔对随机临床试验贡献的简史。
Clin Trials. 2022 Apr;19(2):127-136. doi: 10.1177/17407745211066498. Epub 2022 Jan 6.
2
Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.当代早期乳腺癌中蒽环类药物的应用：综述。
Curr Treat Options Oncol. 2018 May 11;19(6):30. doi: 10.1007/s11864-018-0547-8.
3
The Globalization of Cooperative Groups.合作团体的全球化
Semin Oncol. 2015 Oct;42(5):693-712. doi: 10.1053/j.seminoncol.2015.07.003. Epub 2015 Jul 10.
4
Management of breast cancer: what do I tell the patient?
Can Fam Physician. 1986 Jan;32:99-102.
5
Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy.采用改良根治性乳房切除术、放射治疗和化学疗法对乳腺癌进行初次治疗。
Ann R Coll Surg Engl. 1980 Jan;62(1):45-9.
6
Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer.II期乳腺癌辅助细胞毒性化疗后外周血细胞数量的延迟恢复。
Cancer Chemother Pharmacol. 1981;7(1):37-40. doi: 10.1007/BF00258211.
7
The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.手术切除非免疫原性小鼠癌后化疗对隐匿性转移的影响。
J Cancer Res Clin Oncol. 1980;98(3):277-86. doi: 10.1007/BF00410790.
8
Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.结直肠癌的辅助化疗与免疫治疗：初步报告
J R Soc Med. 1980 Mar;73(3):197-9. doi: 10.1177/014107688007300308.
9
Adjuvant chemotherapy for breast cancer: side effects and quality of life.乳腺癌辅助化疗：副作用与生活质量
Br Med J. 1980 Dec 13;281(6255):1594-7. doi: 10.1136/bmj.281.6255.1594.
10
Adjuvant chemotherapy of breast cancer: hope--reality--hazard?乳腺癌辅助化疗：希望——现实——风险？
Klin Wochenschr. 1984 Feb 15;62(4):149-61. doi: 10.1007/BF01731637.